Webinar: The impact of early intervention using SGLT2i in Type 2 Diabetes.
This is a promotional meeting supported and funded by A. Menarini Farmaceutica Internazionale SRL.
Webinar Details
This is a promotional meeting supported and funded by A. Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI code of practice. This meeting is for UK-registered HCPs only.
Webinar: The impact of early intervention using SGLT2i in Type 2 Diabetes.
Date: Wednesday 18th March
Time: 1pm - 2pm
Key takeaways:
- The importance of early intervention in T2D
- The role of SGLT2i in T2D management and achieving a legacy effect Case study
Chair:
Minesh Parbat, PCPA Regional Vice-President, ICS Chief Pharmacist and Clinical Director Pharmacy and Medicines Optimisation, NHS Shropshire, Telford and Wrekin
Speaker
Emann El-Abiary,
Clinical Pharmacist with Special Interest in Diabetes
Emann is a pharmacist with over 15 years of patient-focused experience across community and primary care. She began her primary care career as a minor ailments pharmacist and subsequently developed advanced clinical expertise across a wide range of long-term conditions, completing a Master’s degree in Advanced Clinical Practice (ACP).
Emann has worked with diverse populations across multiple communities, gaining insight into varied patient demographics and healthcare needs. More recently, she has developed a specialist interest in diabetes, with a focus on improving outcomes for patients whose risks remain under-recognised and under-addressed, despite a growing evidence base supporting early intervention.
February 2026 | PP-IN-UK-3346
